English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52913588    線上人數 :  628
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"yu yun shao"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 26-50 / 113 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-02-25T07:00:57Z It takes two to tango: breakthrough advanced hepatocellular carcinoma treatment that combines anti-angiogenesis and immune checkpoint blockade Liu T.-H.; YU-YUN SHAO; Hsu C.-H.
臺大學術典藏 2021-02-25T07:00:57Z Total skeletal, psoas and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma Wu C.-H.; Liang P.-C.; Hsu C.-H.; Chang F.-T.; YU-YUN SHAO; Ting-Fang Shih T.
臺大學術典藏 2021-02-25T07:00:57Z Hepatitis B virus infection and the risk of cancer among the Chinese population Tian T.; Song C.; Jiang L.; Dai J.; Lin Y.; Xu X.; Yu C.; Ge Z.; Ding Y.; Wen Y.; Liu B.; YU-YUN SHAO; Shi P.; Zhu C.; Liu Y.; Jing S.; Wang Z.; Hu Z.; Li J.
臺大學術典藏 2021-02-25T07:00:56Z Reply to letter to the editor: Low skeletal muscle mass are predictive factors of survival for advanced hepatocellular carcinoma Wu C.-H.; YU-YUN SHAO; Ting-Fang Shih T.
臺大學術典藏 2021-01-18T09:11:58Z The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma YI-PING HUNG; YU-YUN SHAO; Chiun Hsu; CHIH-HUNG HSU; Lee, Jan Mou; Yang, Muh Hwa; Chao, Yee
臺大學術典藏 2020-04-10T12:16:14Z Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma Lin Z.-Z.; Liang P.; Huang C.; YU-YUN SHAO
臺大學術典藏 2020-04-10T12:16:14Z Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions YU-YUN SHAO; Hu F.-C.; Liang J.-T.; Chiu W.-T.; Cheng A.-L.; Yang C.-H.
臺大學術典藏 2020-04-10T12:16:14Z Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma Cheng A.-L.; Hsu C.; Ding Y.-H.; YU-YUN SHAO; Chen P.-J.; Lin Z.-Z.; Shen Y.-C.; Hsu C.-H.
臺大學術典藏 2020-04-10T12:16:14Z Gastric perforation presenting as empyema in a patient with pancreatic cancer on bevacizumab treatment Tien Y.-W.; Cheng A.-L.; Liang P.-C.; YU-YUN SHAO; Lin Z.-Z.
臺大學術典藏 2020-04-10T12:16:13Z Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma YU-YUN SHAO; Lin Z.-Z.; Hsu C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:13Z Pleural metastases as a unique entity with dismal outcome of head and neck squamous cell carcinoma YU-YUN SHAO; Hong R.-L.
臺大學術典藏 2020-04-10T12:16:13Z Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer. YU-YUN SHAO; Lin C.C.; Yang C.H.
臺大學術典藏 2020-04-10T12:16:13Z Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin YU-YUN SHAO; Kuo K.-T.; Hu F.-C.; Lu Y.-S.; Huang C.-S.; Liau J.-Y.; Lee W.-C.; Hsu C.; Kuo W.-H.; Chang K.-J.; Lin C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:12Z Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma YU-YUN SHAO; Lin Z.-Z.; Hsu C.; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:12Z High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapy YU-YUN SHAO; Lin Z.-Z.; Chen T.-J.; Hsu C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:12Z Increasing incidence of brain metastasis in patients with advanced Hepatocellular carcinoma in the era of Antiangiogenic targeted therapy YU-YUN SHAO; Lu L.-C.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2020-04-10T12:16:12Z Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinoma YU-YUN SHAO; Chen P.-J.; Lin Z.-Z.; Huang C.-C.; Ding Y.-H.; Lee Y.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:11Z Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma Shau W.-Y.; YU-YUN SHAO; Yeh Y.-C.; Lin Z.-Z.; Kuo R.; Hsu C.-H.; Hsu C.; Cheng A.-L.; Lai M.-S.
臺大學術典藏 2020-04-10T12:16:11Z Survival of patients with small cell lung carcinoma in Taiwan Kuo Y.-H.; Lin Z.-Z.; Yang Y.-Y.; YU-YUN SHAO; Shau W.-Y.; Kuo R.N.C.; Yang J.C.-H.; Lai M.-S.
臺大學術典藏 2020-04-10T12:16:10Z Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems YU-YUN SHAO; Lu L.-C.; Lin Z.-Z.; Hsu C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:10Z Survival following surgery with or without adjuvant chemotherapy for stage I-IIIA non-small cell lung cancer: An East Asian population-based study Lin Z.-Z.; Shau W.-Y.; YU-YUN SHAO; Yang Y.-Y.; Kuo R.N.-C.; Yang J.C.-H.; Laie M.-S.
臺大學術典藏 2020-04-10T12:16:10Z Dissimilar immunohistochemical expression of ERK and AKT between paired biopsy and hepatectomy tissues of hepatocellular carcinoma Cheng A.-L.; YU-YUN SHAO; Chen C.-L.; Ho M.-C.; Huang C.-C.; Tu H.-C.; Hsu C.-H.
臺大學術典藏 2020-04-10T12:16:10Z Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer Yeh K.-H.; Cheng A.-L.; Lin Y.-L.; Hsu C.; Cheng W.-F.; Hsu C.-H.; YU-YUN SHAO; Lu L.-C.
臺大學術典藏 2020-04-10T12:16:10Z Serum insulin-like growth factor-1 levels predict outcomes of patients with advanced hepatocellular carcinoma receiving antiangiogenic therapy YU-YUN SHAO; Huang C.-C.; Lin S.-D.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:09Z Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study Hsu C.; Cheng A.-L.; Jin K.; Hsu C.-H.; Kang Y.K.; Yang T.-S.; Shun C.-T.; YU-YUN SHAO; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.

顯示項目 26-50 / 113 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目